In the realm of modern healthcare, advancements in technology have unlocked innovative solutions to some of humanity’s most pressing medical challenges. At the forefront of this transformation stands Islombek Abdulakhatov, a visionary entrepreneur and the Founder/CEO of Aorta Vision. This groundbreaking startup is revolutionizing disease detection through non-invasive eye scans, ushering in a new era of early diagnosis and personalized healthcare.
Aorta Vision, under the leadership of Islombek Abdulakhatov, is on a mission to change the landscape of healthcare by harnessing the potential of non-invasive eye scans to identify a diverse range of diseases. Through a fusion of artificial intelligence and cutting-edge imaging technology, the company aims to detect conditions like high blood pressure, diabetes, various types of cancer (blood, tissue, and skin), heart disease, stroke, vascular disease, and brain tumors at their earliest stages. Furthermore, AI algorithms are harnessed to identify indicators of schizophrenia and autism spectrum disorder through eye movement patterns and spot analysis.
The journey of Islombek Abdulakhatov is a testament to the power of knowledge, determination, and the pursuit of innovation. Born in Uzbekistan, Islombek Abdulakhatov pursued a Computer Science major at San Francisco State University, successfully completing his degree in 2022. During his tenure at HITIN Scientific Research Organization, he played a pivotal role in developing the biotechnology device TOR, which is used in cancer treatment and was used as a defense against COVID-19. His contributions extended further as he secured patents for groundbreaking projects such as automated analysis for the diagnosis of Hemorrhagic Diathesis and “INFRASAN,” a spectral emissions analysis tool for soil composition.
Islombek’s journey continued with roles at AZT Autos and Bank of America, where his expertise as a software developer flourished. These experiences served as a fertile ground for his vision of Aorta Vision to take root. Combining his technical prowess with his passion for improving healthcare, he founded Aorta Vision to bring revolutionary AI-driven disease detection to the masses. Aorta Vision’s impact is far-reaching, with clients ranging from hospitals and insurance companies to mental health centers, courts, border controls, and government agencies. This broad spectrum of applications underscores the versatility and significance of the technology Islombek Abdulakhatov has pioneered.
Beyond his role as a startup founder, Islombek is an active member of prestigious professional organizations, including the American Association for the Advancement of Science, the Institute of Electrical and Electronic Engineering, and the American Biotechnology Association. By actively participating in these organizations, he demonstrates his unwavering dedication to keeping up with the latest industry developments and cultivating partnerships that push the boundaries of innovation. Islombek Abdulakhatov has authored numerous research papers delving into the realms of Computer crime and Artificial Intelligence.
Islombek’s dedication to his craft is evident in his continuous pursuit of knowledge. With certifications in Artificial Intelligence and Machine Learning, as well as Biotechnology/Biotech Business, Law, Policy, and Science, he stands as a multidisciplinary force poised to reshape the future of the healthcare and IT industry. He is organizing presentations and masterclasses focused on Software development and AI; Islombek Abdulakhatov imparts his extensive expertise in the intricate details of the Biotech and AI sectors to emerging professionals. His involvement in these educational endeavors is driven by a genuine aspiration to foster success among individuals navigating an industry renowned for its competitive challenges.
As the CEO and Founder of Aorta Vision, Islombek Abdulakhatov stands as a beacon of hope in the quest for early disease detection, personalized medicine, and improved patient outcomes. His journey exemplifies the transformative potential of blending technology, innovation, and a relentless commitment to improving the human condition. With his vision, Aorta Vision is destined to leave an indelible mark on the healthcare landscape, one scan at a time.
